EDIT-B®
Blood test to differentiate unipolar depression from bipolar disorder
EDITOX®
Cell-based solutions to mimic drug impact on RNA editing
EDITECH®
Integrated platform from RNA / DNA sequencing to machine learning and AI
White Paper
ALCEDIAG’s White Paper “Precision Psychiatry: Advancing Biomarker-Based Diagnosis in Mental Health” is now available !
Discover how precision psychiatry is transforming mental health care by optimizing diagnosis and therapeutic decision-making.
Innovative Diagnostic Company
ALCEDIAG is an innovative diagnostic company specializing in the development and commercialization of blood tests, monitoring solutions, and companion diagnostics, primarily for mental health. These offerings are based upon the company’s distinctive expertise in epigenetics, RNA, and Artificial Intelligence, complemented by neurosciences and psychiatry.
ALCEDIAG’s unique approach is protected by seven patent families and supported by a global network of Key Opinion Leaders, who serve both as advocate for and early adopt of ALCEDIAG’s solutions.